KRISTEN BASS: Open Payments
NPI 1093015885 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 45 payments from 14 companies in 2025. Trend: 2023 $1,130 · 2024 $925 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $306 |
| Amgen Inc. | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $78 |
| PFIZER INC. | 3 | $59 |
| Novo Nordisk Inc | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Abbott Laboratories | 2 | $31 |
| Lilly USA, LLC | 1 | $21 |
| Recor Medical Inc | 1 | $19 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, OTEZLA, VOQUEZNA, Ozempic, JARDIANCE, FREESTYLE LIBRE 3.
Industry payments across LA — which companies pay providers there.
